Prevention of Asthma With Levocetirizine 18 Month Treatment in Infants (12 - 24 Months) Suffering From Eczema (Atopic Dermatitis) and Sensitized to Grass Pollen and/or House Dust Mite (HDM)

• Status: Completed
• Trial end date: 2006-03-15

Summary

The Early Prevention of Asthma in Atopic Children (EPAAC™). 24 months study to evaluate the efficacy and safety of levocetirizine (LCTZ) in preventing the onset of asthma in 12 to 24 months old children.

• Phase: Phase 3

Details

• Lead Sponsor: UCB Pharma; UCB Pharma SA
• Treatments: Cetirizine; Levocetirizine